Navigation Links
One A Day(R) and Major League Baseball Raise Over $106,000 to Strike Out Prostate Cancer
Date:6/2/2008

MORRISTOWN, N.J., June 2 /PRNewswire/ -- Watching your favorite player strike out isn't usually cause for celebration, but for One A Day(R) multivitamins and Major League Baseball (MLB) strikeouts are leading to big wins. The makers of One A Day and MLB announced today the latest results of the "One A Day Men's Presents the MLB Strike Out Prostate Cancer Challenge." Created earlier this year as part of an exclusive partnership between MLB and One A Day, the program has raised $106,120 to date for the Prostate Cancer Foundation.

As part of the program, One A Day and MLB will donate $10 for every strikeout throughout the 2008 Major League Baseball season to the Prostate Cancer Foundation, the world's largest philanthropic source of support for prostate cancer research. An additional $1 million will be donated if any one pitcher achieves 21 strikeouts in a nine-inning game to set a new MLB record. The goals of the program are to raise funds to support research to find a cure for prostate cancer and to raise awareness about the importance of maintaining prostate health through proper nutrition and early detection of problems.

"We are thrilled that One A Day and Major League Baseball have come together to raise awareness and funds to help find better treatments and a cure for prostate cancer," said Dave Perron, Vice President, Baseball and Sports Enterprises for the Prostate Cancer Foundation. "With these two strong organizations in the fight, we know we'll be able to do even more to find a cure for this deadly disease."

Prostate cancer is a disease one in every six men will be diagnosed with during his lifetime. For Chicago White Sox designated hitter and program spokesperson Jim Thome, the disease hits very close to home.

"Prostate cancer affects far too many men each year including members of my own family," said Thome. "So, getting involved in this program with One A Day was a no brainer. I want to do all I can to spread the word ab
'/>"/>

SOURCE Bayer HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MedPage Today(R) Selects iSEEK(TM) to Improve Quality of Patient Care
2. MedPage Today(R) Provides First-Time Live Video Coverage of Medical Meeting Press Conferences
3. MedPage Today(R) Wins Prestigious eHealthcare Leadership Award
4. Today(R) Sponge to be Distributed in Hong Kong and Macau
5. MedPage Today(R) Continuing Medical Education Activities Now Offer AAPA Credit for Physician Assistants
6. Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference
7. Harvard Medical School receives major NIH grant for galvanizing translational science
8. AHCA, Alliance Warn Rural Seniors Will Bear Major Brunt of Bush Administrations Medicare Cuts
9. Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants
10. Major missed biochemical pathway emerges as important in virtually all cells
11. MedQuist to Get New Majority Stakeholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... (PRWEB) March 28, 2015 Could genetic ... a new study by researchers at the ... Produced with the support of the Coffee and Caffeine ... Molecular Psychiatry this past fall, the study—one of several ... of genomic data from more than 120,000 regular coffee ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians ... osteoarthritis and musculoskeletal diseases gathered here for the ... first time in the 17-year history of the ... topic is an emerging non-pharmaceutical protocol for enhancing ... of Wolff’s law, osteogenic loading at multiples of ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New ... recently commemorated its three-year anniversary of being the only ... to 24-hour urgent care, Emergency Medical Care offers its ... time, Emergency Medical Care’s Urgent Care NYC ... eye injuries, ear infections, fevers, insect bites, burns, animal ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site ... their Las Vegas warehouse, located at 4606 Andrews St. Suite ... of equipment from hospitals and surgery centers from around the ... , Buyers will find items of all types including anesthesia, ... said Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... How best to treat and recover from ... medicine. While diagnostic hip injections are commonly performed for ... research presented today at the American Orthopaedic Society for ... pain relief from this diagnostic injection may not predict ... study looked to assess if the amount of pain ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... prime minister Jose Socrates is smiling. His move to lift a ... voting doing so in favor of the ban being lifted or, ... and Poland- strong catholic nations that prohibit abortion or destruction of ... abort can face up to 3 years prison term and those ...
... monitored more carefully according to reports sounded at the ... a higher risk of giving birth to still-born babies, than ... Yale School of Medicine, who put forward results made after ... ,It was seen that the risk of intrauterine fetal ...
... increases a woman’s risk of becoming infected with HIV, ... edition of The Journal of Infectious Diseases (now online). ... sexually transmitted infections increase the risk of transmission and ... of Trichomonas vaginalis per year worldwide, there are few ...
... alloy surfaces containing at least 90 per cent copper completely ... of the pathogen-killing// properties of the metal. ,The ... on the mix of metals they use to coat the ... better means of eliminating E coli contamination in their products. ...
... The South African AIDS Vaccine Initiative (SAAVI) and the HIV ... of a Phase IIb study utilizing// Merck’s adenovirus trivalent (Ad5 ... and women over a year, and expect the study to ... (HVTN 502) began enrolling in North and South America, the ...
... Researchers at Cold Spring Harbor Laboratory (CSHL) have solved ... critical tumor suppressor gene, but have revealed// a master ... targeted and effective cancer therapy in the future," said ... by Mills, was published in the February issue of ...
Cached Medicine News:Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 3Health News:Copper Alloys Surfaces Touted As Pathogen Killers 2Health News:Largest Ever African HIV Vaccine Trial Opens in South Africa 2Health News:Scientists Discover New Gene 2
(Date:3/27/2015)... BEIJING , March 27, 2015 ... the "Company") (NYSE: CCM ), a leading ... the largest network of radiotherapy and diagnostic imaging ... announced the signing of a purchase agreement under ... wholly owned subsidiary of the Company, agreed to ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... with a focus on Omega-3 therapies for cardiovascular disease ... it issued 763,752 common shares of the Corporation (the ... for the period of December 5 th , 2014 ... Convertible Notes that is due on or before April ...
(Date:3/26/2015)... March 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... clinical developments and announced fourth quarter and year ... Developments and Anticipated Near-term MilestonesCustirsen , ... to negotiate the termination of their collaboration and ... final termination agreement are ongoing. , Two ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... 2011 Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, ... the companies have begun enrolling patients in a ... (sorafenib) tablets in combination with the oral chemotherapeutic ... treatment of patients with advanced breast cancer. This ...
... OSAKA, Japan, February 23, 2011 Takeda Pharmaceutical ... Research & Development Center, Inc. U.S., submitted a ... and Drug Administration (FDA) for an investigational fixed-dose ... the treatment of hypertension, or high blood pressure. ...
Cached Medicine Technology:Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 2Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 3Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 4Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 5Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 6Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer 7Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 2Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 3
... Clinical is an open platform for clinical diagnostic ... deck sizes of 75, 100, 150 and ... for your laboratory space and throughput requirements. Tecan ... to allow new applications and to evolve the ...
... maximum productivity, and proven reliability, Sorvall ... fully automatic cell washing and centrifugation ... 80-second wash cycle for stat testing, ... and standardized, reproducible procedures. High reliability, ...
Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....
... model centrifuge. High throughput, refrigeration maintains ... with all windshield rotors, lifetime reproducibility, ... a remote personal computer or laboratory ... imbalance detection and shut down, armor ...
Medicine Products: